A 36-week multicenter, randomized, double-blind, placebo-controlled,parallel-group, Phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer disease
作者:XIAO; Shi-fuclinicaltrialsodiumoligomannatealzheimerdisease
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社